Incyte EPS (Diluted) increased by 0.7% to $1.47 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 83.7%, from $0.80 to $1.47. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a 10.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.67 | $0.82 | $2.54 | $0.17 | $0.72 | $0.50 | $0.12 | $0.10 | $0.90 | $0.76 | $0.89 | $0.75 | -$2.04 | $0.54 | $0.95 | $0.80 | $2.04 | $2.11 | $1.46 | $1.47 |
| QoQ Change | — | +22.4% | +209.8% | -93.3% | +323.5% | -30.6% | -76.0% | -16.7% | +800.0% | -15.6% | +17.1% | -15.7% | -372.0% | +126.5% | +75.9% | -15.8% | +155.0% | +3.4% | -30.8% | +0.7% |
| YoY Change | — | — | — | — | +7.5% | -39.0% | -95.3% | -41.2% | +25.0% | +52.0% | +641.7% | +650.0% | -326.7% | -28.9% | +6.7% | +6.7% | +200.0% | +290.7% | +53.7% | +83.7% |